Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $75.62 USD
Change Today +1.50 / 2.02%
Volume 694.1K
ABMD On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

abiomed inc (ABMD) Snapshot

Open
$74.70
Previous Close
$74.12
Day High
$76.05
Day Low
$73.60
52 Week High
05/5/15 - $76.90
52 Week Low
10/13/14 - $21.84
Market Cap
3.2B
Average Volume 10 Days
620.4K
EPS TTM
$0.69
Shares Outstanding
42.1M
EX-Date
--
P/E TM
110.2x
Dividend
--
Dividend Yield
--
Current Stock Chart for ABIOMED INC (ABMD)

Related News

No related news articles were found.

abiomed inc (ABMD) Related Businessweek News

No Related Businessweek News Found

abiomed inc (ABMD) Details

ABIOMED, Inc. researches, develops, and sells medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP that provides partial circulatory support using an extracorporeal bypass control unit; Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; and Impella RP, a percutaneous catheter-based axial flow pump. It also manufactures and sells AB5000 circulatory support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, the company provides Symphony, a synchronized minimally invasive implantable cardiac assist device designed to treat chronic patients with moderate heart failure by improving patient hemodynamics. Further, it engages in the research, development, prototyping, and production of a percutaneous expandable catheter pump, which enhances blood circulation from the heart with an external drive shaft. The company sells its products through direct sales and clinical support personnel in the United States, Germany, France, Canada, Japan, and the United Kingdom. ABIOMED, Inc. was founded in 1981 and is headquartered in Danvers, Massachusetts.

589 Employees
Last Reported Date: 05/28/15
Founded in 1981

abiomed inc (ABMD) Top Compensated Officers

Chairman, Chief Executive Officer, President,...
Total Annual Compensation: $537.9K
Chief Operating Officer
Total Annual Compensation: $350.4K
Vice President and General Manager of Global ...
Total Annual Compensation: $306.7K
Senior Vice President of Global Product Opera...
Total Annual Compensation: $294.6K
Consultant
Total Annual Compensation: $323.3K
Compensation as of Fiscal Year 2015.

abiomed inc (ABMD) Key Developments

ABIOMED, Inc. Presents at William Blair’s 35th Annual Growth Stock Conference, Jun-10-2015 10:00 AM

ABIOMED, Inc. Presents at William Blair’s 35th Annual Growth Stock Conference, Jun-10-2015 10:00 AM. Venue: Four Seasons Hotel, Chicago, Illinois, United States. Speakers: Michael R. Minogue, Chairman, Chief Executive Officer, President, Member of Special Stock Option Committee and Member of Executive Committee.

Abiomed Announces Executive Changes

Abiomed, Inc. announced that Robert Bowen, the company's Vice President and Chief Financial Officer since 2008, who will celebrate his 66th birthday this summer will retire from Abiomed next month and that Michael Tomsicek will be appointed as Vice President and Chief Financial Officer, effective July 15, 2015. Mr. Bowen will continue to support the Company in a consulting role to facilitate a smooth transition. Mr. Tomsicek, 49, joins Abiomed after he most recently served as CFO of Cubist Pharmaceuticals.

ABIOMED, Inc. Presents at Jefferies 2015 Global Healthcare Conference, Jun-03-2015 02:00 PM

ABIOMED, Inc. Presents at Jefferies 2015 Global Healthcare Conference, Jun-03-2015 02:00 PM. Venue: The Grand Hyatt Hotel, New York, New York, United States. Speakers: Michael R. Minogue, Chairman, Chief Executive Officer, President, Member of Special Stock Option Committee and Member of Executive Committee.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABMD:US $75.62 USD +1.50

ABMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Hansen Medical Inc $0.87 USD -0.0056
LeMaitre Vascular Inc $12.78 USD +1.54
Stereotaxis Inc $1.44 USD 0.00
Spectranetics Corp/The $17.19 USD +1.54
Thoratec Corp $63.13 USD +0.03
View Industry Companies
 

Industry Analysis

ABMD

Industry Average

Valuation ABMD Industry Range
Price/Earnings 27.9x
Price/Sales 13.2x
Price/Book 10.5x
Price/Cash Flow 27.4x
TEV/Sales 13.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ABIOMED INC, please visit www.abiomed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.